Melanoma shows a remarkable capacity for phenotypic adaptation: single-cell follow-up studies have shown that under the action of a stress (such as treatment with BRAF inhibitors), a part of melanoma cells can non-genetically escape the therapeutic pressure by rapidly entering a persistent state that allows them to proliferate in the presence of the drug. The gene discussed is BRAF; the disease is melanoma.